[Pyknoleptic petit mal and secondary grand mal].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001463:Barbiturates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004522:Educational Status; D004832:Epilepsy, Absence / Q000150:complications / Q000188:drug therapy*; D004830:Epilepsy, Tonic-Clonic / Q000209:etiology / Q000517:prevention & control*; D005013:Ethosuximide / Q000627:therapeutic use; D005260:Female; D005860:Germany, West; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use; D008297:Male; D010080:Oxazoles / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies
D001463:Barbiturates; D006827:Hydantoins; D010080:Oxazoles; D011324:Primidone; D005013:Ethosuximide
Pyknoleptisches Petit mal und sekundäres Grand mal